Is it time to refine HCC surveillance strategies in HCV cured patients?
Hepatology
.
2022 Jul;76(1):9-11.
doi: 10.1002/hep.32430.
Epub 2022 Mar 19.
Authors
Roberta D'Ambrosio
1
,
Pietro Lampertico
1
2
Affiliations
1
Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
2
Department of Pathophysiology and Transplantation, CRC "A. M. and A. Migliavacca" Center for Liver Diseases, University of Milan, Milan, Italy.
PMID:
35218241
DOI:
10.1002/hep.32430
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents / therapeutic use
Carcinoma, Hepatocellular* / drug therapy
Hepatitis C* / complications
Hepatitis C* / drug therapy
Humans
Liver Cirrhosis / epidemiology
Liver Neoplasms* / drug therapy
Substances
Antiviral Agents